Phytomedicine Plus 2 (2022) 100182
Contents lists available at ScienceDirect
Phytomedicine Plus
journal homepage: www.sciencedirect.com/journal/phytomedicine-plus
Phytochemical characterization, antihyperglycaemic and
antihyperlipidemic activities of Setaria megaphylla in alloxan-induced
diabetic rats
Jude E. Okokon a, 1, *, Koofreh Davies b, 3, Lekara John b, 2, Klinton Iwara b, 2, Wen-Wu Li c, 5,
Paul S. Thomas d, 4
a
Department of Pharmacology and Toxicology Faculty of Pharmacy, University of Uyo, Uyo, Nigeria
Department of Physiology, Faculty of Basic Medical Sciences, University of Uyo, Uyo, Nigeria
c
School of Pharmacy and Bioengineering, Faculty of Medicine and Health Science, Keele University, Stoke-on-Trent, ST4 7QB, United Kingdom
d
Department of Pharmacognosy and Natural Medicine, Faculty of Pharmacy, University of Uyo, Uyo, Nigeria
b
A R T I C L E I N F O
A B S T R A C T
Keywords:
Diabetes mellitus
Medicinal plants
Hypoglycaemic agents
Insulin
1-Triacontanol
Stigmasterol
Background: Setaria megaphylla (Steud) Dur & Schinz (Poaceae), a grass used ethnomedically by herbalists in
Nigeria for the treatment of diabetes was evaluated for antidiabetic, hypolipidemic and pancreas protective
potentials in rats.
Methods: Solvents fractions (hexane, dichloromethane (DCM), ethyl acetate (EA) and methanol ) were investigated for antidiabetic, hypolipidemic and pancreas protective potentials in alloxan-induced diabetic rats. Glibenclamide was used as positive control. The fasting blood glucose (FBG) level, serum insulin, glycosylated
hemoglobin (Hb1Ac), oral glucose tolerance test (OGTT) and lipids levels were determined. Histopathological
study of the pancreas was done. Isolation of phytochemicals and their subsequent identification using Fourier
transform infrared spectroscopy, gas chromatography-mass spectrometry and nuclear magnetic resonance
spectroscopy were carried out.
Results: Treatment of alloxan-induced diabetic rats with the leaf fractions caused significant (p < 0.05–0.001)
reduction in FBG of treated diabetic rats in acute and prolonged studies as well as OGTT with DCM, EA and
hexane fractions having pronounced activities. The leaf fractions also caused significant (p < 0.01) decreases in
Hb1Ac levels and increases in serum insulin levels. The leaf fractions further caused lowering of serum total
cholesterol, triglycerides, low density lipoprotein (LDL), very low density lipoprotein (VLDL) with increased high
density lipoprotein (HDL) level in the treated diabetic rats. Histopathological study of pancreas revealed protective effect by the leaf fractions. 1-Triacontanal, 1-triacontanol, 1-dotriacontanol, 1-triacontyl cerotate, and
stigmasterol were isolated and identified from the active DCM and EA fractions of this plant for the first time .
Conclusion: The leaf fractions of S.megaphylla possess hypoglycemic, insulin secretion stimulatory, hypolipidemic,
and pancreas protective potentials which may be due to the activities of the phytochemical constituents.
List of abbreviations
DCMDichloromethane
EAFBGOGTT-
Ethyl acetate
Fasting blood glucose
Oral glucose tolerance test
; ATR, Attenuated total reflection; FT-IR, Fourier transform infrared spectroscopy; ROS, Reactive oxygen species.
* Corresponding author.
E-mail address: judeokokon@uniuyo.edu.ng (J.E. Okokon).
1
Jude E. Okokon designed and supervised the work
2
Lekara John and Klinton Iwara carried the animal studies
3
Koofreh Davies did the statistical analysis
4
Paul S. Thomas carried out the isolation and purification of the compounds
5
Li Wen Wu did the GC–MS and NMR analysis and interpretation of the spectra and also edited the work.
https://doi.org/10.1016/j.phyplu.2021.100182
Received 19 October 2021; Received in revised form 15 November 2021; Accepted 27 November 2021
Available online 30 November 2021
2667-0313/© 2021 The Authors.
Published by Elsevier B.V. This is an open access
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
article
under
the
CC
BY-NC-ND
license
J.E. Okokon et al.
Hb1AcGC–MSNMRLDLVLDLHDLWHOH & ET C-
Phytomedicine Plus 2 (2022) 100182
Materials and methods
Glycosylated hemoglobin
Gas chromatography-mass spectrometry
Nuclear magnetic resonance spectroscopy
Low density lipoprotein
Very low density lipoprotein
High density lipoprotein
World Health Organisation
Heamatoxylin and eosin
Total cholesterol
Plant material and extraction
Fresh leaves of the plant were collected from Akwa Anwa forest,
Uruan in Akwa Ibom State, Nigeria in August 2020 and identified by a
taxonomist in the Department of Botany, University of Uyo, Uyo. A
voucher specimen (UUPH. 221 d) of the plant was deposited at herbarium of Department of Pharmacognosy and Natural Medicine, University of Uyo, Uyo. The leaves were washed, chopped into pieces, dried
and powdered. The powder (1.5 kg) was successively and gradiently
macerated in 7.5 L of each of these solvents at room temperature (28 ±
2 ◦ C) for 72 h; n-hexane, dichloromethane (DCM), ethyl acetate (EA) and
methanol to give corresponding their fractions. The liquid filtrates obtained were concentrated to dryness at 40 ◦ C using rotary evaporator
and these were preserved in a desicator until used for the proposed
experiments.
Introduction
Diabetes mellitus (DM) is a chronic metabolic disease affecting
economic and social activities of all countries of the world with estimated millions of deaths worldwide due to high blood glucose and risks
of associated complications, which often result in premature death
(WHO, 2017). There are three major types of DM: type 1 diabetes
(T1DM, insulin dependent), type 2 diabetes mellitus (T2DM), and
gestational diabetes mellitus. T2DM contributes to more than 90% of all
DM cases. According to International Diabetes Federation in 2019, the
total adult population stands at 463 million with diabetes, which may
increase to 578 million and 700 million by 2030 and 2045, respectively
(Saeedi et al., 2019). The increasing prevalence of diabetes is worrisome
and calls for an urgent remedial steps as the orthodox medicines used in
the management of DM seem to be inadequate and challenging (Saeedi
et al., 2019). The current use of orthodox drugs and insulin in the
management of diabetes does not offer satisfactory treatment outcome
as the drugs are associated with unpleasant side effects such as hypoglycemia, hypersensitivity, gastrointestinal disturbances, hepatotoxicity, renotoxicity and heart failure ((Basu et al., 2015); Sudasinghe and
Peiris,2018). Herbal preparations are highly patronized for the management of diabetes due to their low cost, accessibility, relative safety
and many biological activities compared to conventional anti-diabetic
drugs (Badri et al., 2006; Khan et al., 2012; Peiris et al., 2015). Medicinal plants have been extensively investigated for the potential treatment of DM (Marles and Farnsworth, 1995; Ezuruike and Prieto, 2014;
Tran et al., 2020). Various phytochemicals such as ginsenosides in Panax
ginseng, cucurbitane type terpene glycosides in Momordica charantia,
glycyrrhizin in Glycyrrhiza glabra and berberines in Coptis chinensis have
been found to possess antidiabetic activity (Park and Jang, 2017). In
particular, metformin, one of the most common drugs for DM, is derived
from guanidine compounds in Galega officinalis (Bailey, 2004). Hence
there is the need to search for new antidiabetic compounds from medicinal plants with potentials to circumvent the present challenges faced
in DM management.
Setaria megaphylla (Steud) Dur & Schinz (Poaceae) is a perennial
pasture grass distributed widely in tropical and subtropical countries of
the world (Van Oudtshoorn, 1999). It is called ‘nkwongo’ in ibibio or
broad leafed brittle grass. Although no detailed ethnopharmacological
survey has been carried out on medicinal plants used by the Ibibios in
Akwa Ibom State, reports of ethnomedicinal use of the plant (leaves and
roots) by herbalists from Ibibio tribe in Niger Delta region of Nigeria for
the treatment of diabetes have been published (Okokon et al., 2006;
Okokon and Antia, 2007, 2007a). Preliminary reports indicated antidiabetic and hypoglycaemic activities of the leaves and roots (Okokon and
Antia, 2007; Okokon et al., 2007a). Other activities of the leaves
include; in vitro and in vivo antimalarial (Clarkson et al., 2004; Okokon
et al., 2007b, 2017), anti-inflammatory, analgesic (Okokon et al., 2006),
cytotoxic, immunomodulatory and antileishmanial (Okokon et al.,
2013) and antidepressant (Okokon et al., 2016). Phytochemical constituents of the leaf extract identified through various screening and
analytical methods have been reported (Okokon et al., 2006; Okokon
et al., 2013). Here, we report the antihyperglycaemic and hypolipidemic
potentials of the solvent leaf fractions of Setaria megaphylla in
alloxan-induced diabetic rats, and further isolation and identification of
phytochemicals in these fractions.
Purification of compounds from dichloromethane and ethyl acetate
fractions of Setaria megaphylla
Dichloromethane and ethyl acetate fractions (15 g) found to be
active during the experiment were bulked and subjected to silica gel
column chromatography (Merck, 60–120 mesh) and gradient-eluted
with n-hexane containing increasing quantity of dichloromethane, followed by increasing quantity of ethyl acetate and methanol. Eluates (20
mL each) were collected, monitored on silica thin layer chromatography
(TLC) plates (Merck, Germany) in hexane: DCM: EA (2:1:1) using
vanillin-sulphuric acid as spray reagent. Fifty-one fractions were obtained and bulked together based on their similar TLC characteristics (Rf
values, color reaction with spray reagents) to give four semi-pure residues coded F1–F4. F2 was further purified using preparative TLC;
carefully dissolved in dichloromethane and applied across the coated
silica gel plate (20 × 20 cm, 0.25 mm) using a micro-Pasteur pipette
(Simax, India) 1 cm above the bottom edge of the plate. The plates were
developed using n-hexane: dichloromethane (4:1) solvent system in a
Chromatank (USA). The chromatogram obtained showed two distinctly
resolved layers which were carefully scrapped, separated, filtered and
concentrated in vacuo. Further TLC evaluations indicated a single spot in
each layer which were denoted X1 (10 mg) and X16/17 (8 mg). F3 on
further purification with preparative TLC using hexane and dichloromethane (1:4) yielded one pure compound N15 (10 mg). Purification of
F4 with preparative TLC using hexane and DCM (4:1) produced a pure
compound PJ3 (8 mg). This was filtered and concentrated to give a
white crystalline compound. The chemical structures of isolated pure
compounds were elucidated using spectroscopic analyses.
Animals
Wistar rats (males and females) used for these experiments were
obtained from Animal house in University of Uyo. The animals were
accommodated in standard plastic cages and maintained on pelleted
Feed (Guinea Feed) and water ad libitum. Permission and approval for
animal studies were obtained from College of Health Sciences Animal
Ethics committee, University of Uyo (UU/CHS/AE/21/024).
Induction of experimental diabetes using alloxan monohydrate
Intraperitoneal injection of freshly prepared alloxan monohydrate
solution (150 mg/kg i.p) in ice cold 0.9% saline (NaCl solution), was
used to induce diabetes in overnight fasted forty (40) Wistar rats (males
and females) weighing (140–160 g). Immediately after the induction, 2
mL of 5% dextrose solution was orally administered to the animals to
reduce the effect of initial hypoglycaemia (Okokon and Nyong, 2018).
Rats with moderate diabetes, (i.e. with blood glucose levels of 200
mg/dL and above), after a post-induction rest period of 72 h, which was
2
J.E. Okokon et al.
Phytomedicine Plus 2 (2022) 100182
allowed for the diabetes to be fully developed (Lenzen, 2008) were
considered diabetic and selected for the experiments.
The sample size for the study was calculated using resource equation
method of Festing (2006) and the diabetic animals were divided into 6
(six) treatment groups of 6 rats each. Based on determined median lethal
dose (LD50) of 2.4 ± 0.5 g/kg, (Okokon et al., al.,2006), the rats were
treated with 200 mg/kg/day of respective solvent fractions of
S. megaphylla leaf orally for 14 days as follows; group 1 was given 10
mL/kg/day of normal saline, group 2, 5 mg/kg/day of glibenclamide,
group 3 – 6 were respectively administered 200 mg/kg/day of n-hexane,
dichloromethane, ethyl acetate and methanol fractions of S. megaphylla
leaf.
(1984).
Determination of the effect of the solvent fractions on the lipid profile
(Serum TG, TC, HDL, LDL, VLDL levels) of the treated diabetic rats
Serum total cholesterol (TC), triglyceride and high density lipoprotein (HDL) levels of the diabetic rats were measured using Randox
diagnostic kits, low and very low-density lipoprotein (LDL and VLDL)
were calculated from the formula of Friedwald et al. (1972).
Gas chromatography-Mass spectrometry (GC–MS) analysis
Assessment of oral glucose tolerance in treated diabetic rats
GC–MS was carried out on an Agilent 7890A gas chromatograph,
coupled with an Agilent MS model 5975C MSD with triple axis detector
(Agilent Technologies, USA). The system was equipped with a HP5-MS
column 5% phenyl-methylpolysiloxane, 30 m × 0.25 mm × 0.25 µm
(Agilent Technologies, USA). The carrier gas was helium with a gas flow
under a constant pressure of 10 psi. The injector temperature was set at
280 ◦ C. The initial oven temperature was 160 ◦ C and increased to 320 ◦ C
at 10 ◦ C/min, and the final temperature was held for 6 min at 320 ◦ C.
The mass spectrometer was operated in the electron ionization mode at
70 eV. The 0.2–0.4 mg of each compounds were dissolved in CHCl3 (5
mg/mL) (X16/17 and PJ3) or treated with N,O-bis(trimethylsilyl)trifluoroacetamide (BSTFA) with 1% trimethylchlorosilane (N15) for 20
min at room temperature before injection of 1 µL to GC–MS system
(Aldulaimi et al., 2017). The compounds were identified by comparison
of spectral data and fragmentation patter with reference compounds in
the NIST 2011 database.
Oral glucose tolerance test (OGTT) was evaluated in a group of 36
diabetic rats induced with diabetes using alloxan as stated above. After
confirmation and selection of the diabetic rats on the 3rd day, the rats
were fasted for 24 h but allowed free access to water. After which the
animals were weighed and randomised into 6 groups of 6 rats each. The
basal Blood glucose levels (BGL) of the animals were determined by tailtipping method using digital Glucometer. Thereafter, the diabetic rats
were orally administered with 200 mg/kg of the respective solvent
fractions (n-hexane, dichloromethane, ethyl acetate and methanol).
Thirty (30) min post-administration of fractions the animals were given
oral glucose load (2 g/kg). BGL were determined at 30, 60, 90, 120 and
180 min post glucose administration (Rabintossaporn et al., 2009;
Okokon and Mandu, 2018).
Determination of hypoglycemic potential of the solvent fractions of S.
megaphylla in alloxan-induced diabetic rats
Nuclear magnetic resonance (NMR) spectroscopy
FBG of diabetic rats were determined at hourly intervals during the
periods of acute study, i.e. 1–3, 5 and 7 h interval, after a single dose of
the fractions and at intervals of 1–3, 5, 7 and 14 days during prolonged
study by “the tail-tipping method” using microprocessor digital blood
glucometer (WHO, 1980).
Administration of fractions and drugs were carried out at a scheduled
time daily and the animals were fasted every evening prior to days for
measurement of the FBG concentrations.
1
H and 13C NMR spectra for the isolated compounds were obtained
on a Bruker 400 and 100 MHz instrument, respectively. Chemical shifts
were reported in δ (ppm) using the solvent CDCl3 or CDCl3 + CD3OD
(9:1) as standard and coupling constants (J) were measured in Hertz.
Fourier transform infrared (FT-IR) spectroscopy
Fourier transform infrared spectrometer (Nicolet AVATAR360,
Thermo Fisher Scientific) fitted with the attenuated total reflection
(ATR) accessory was used to record FTIR spectra with a resolution of 4.0
cm-1 from 4000 to 800 cm-1.
Determination of the body weights changes of the treated diabetic rats
The body weights of the experimental animals were monitored
before and after induction of diabetes and at the end of the study
(Day15).
Statistical analysis
Data obtained from this work are expressed as MEAN ± SEM and
were analysed statistically using one way ANOVA followed by TukeyKramer multiple comparison test using Instat Graphpad software, San
Diego, USA. Differences between means were considered significant at
5% level of significance ie p ≤ 0.05.
Collection of blood samples and organs
Twenty-four (24 h) after 14 days of treatment with fractions/drugs,
the rats were weighed and sacrificed under light diethyl ether vapor.
Blood samples were collected by cardiac puncture into plain centrifuge
tubes and centrifuged immediately at 1500 rpm for 15 min to separate
the serum at room temperature to avoid haemolysis. These blood samples were used for biochemical assays. The pancreas of the diabetic rats
used in the study were surgically removed, weighed, fixed in 10%
formaldehyde, processed, stained using Heamatoxylin and eosin (H & E)
method and microscopically examined under the microscope at
magnification (X400)
Results
Effect of solvent fractions on body and pancreas weights of rats
There were considerable changes in the body weights of the treated
and untreated alloxan-induced diabetic rats (Table 1). Treatment of the
diabetic rats with the leaf fractions caused significant (p < 0.05–0.001)
increases in the body weight of the diabetic rats when compared to
control. The highest increases were recorded in EA fraction-treated
group (9.64%), followed by hexane group (8.30%) (Table 1). Significant (p < 0.001) decreases in the pancreas weights of the diabetic rats
compared to control was observed following treatment of alloxan
–induced diabetic rats with leaf fractions of S. megaphylla with the
hexane fraction exerting the highest reduction (Table 1).
Determination of insulin and glycosylated hemoglobin levels in the diabetic
rats
Serum insulin levels were measured with an ultra-sensitive rat insulin ELISA kit (Alpco Diagnostics) (Finlay and Dillard, 2007), while
glycosylated hemoglobin was measured by method of Nathan et al.
3
J.E. Okokon et al.
Phytomedicine Plus 2 (2022) 100182
and hexane fraction treated groups. This was followed by DCM and EA
groups (Table 2). The serum insulin level of hexane group was comparable to that of the standard drug, glibenclamide (Fig. 2).
Table 1
Effect of leaf fractions of Setaria megaphylla on body and pancreas weights of
diabetic rats.
Treatment
Control normal
saline
Glibenclamide
Dose
mg/
kg
–
10
n-hexane fraction
200
Dichloromethane
fraction
Ethyl acetate
fraction
Methanol fraction
200
200
200
Weight (g)
Day 0
Day 15
154.6 ±
11.18
147.3 ±
0.85
144.96
± 1.81
145.26
± 4.67
144.4 ±
8.50
152.46
± 12.10
148.3 ±
14.60
157.68
± 11.20
157.0 ±
24.61
151.25
± 10.84
158.33
± 16.02
159.33
± 15.16
%
Increase
Weights of
pancreas
(g)
−4.07
0.71 ± 0.03
7.04
8.30
0.44 ±
0.01a
0.50 ± 0.02
4.12
0.53 ± 0.01
9.64
0.54 ± 0.04
4.50
0.58 ± 0.03
Effect of solvents fractions on oral glucose tolerance test (OGTT)
Table 2 shows the effect of different solvent fractions on oral glucose
tolerance test of alloxan-induced diabetic rats. The leaf fractions caused
lowering of BGL of the diabetic rats. These reductions were significant
(p < 0.01–0.05) when compared with control and peaked effects were
recorded at 180 min with the various fractions producing
(34.07–50.29%) inhibition of elevation of BGL, while the methanol
fraction had the highest percentage inhibition of 50.98% followed by
hexane (50.29%) and dichloromethane (43.84%) (Table 4).
a
a
a
Hypolipidemic effect of leaf fractions
a
a
Data are expressed as MEAN ± SEM, Significant at p < 0.001, when compared
to control. (n = 6).
The leaf fractions of S. megaphylla did not cause any significant effect
(p > 0.05) on the levels of total cholesterol, triglyceride, HDL, LDL and
VLDL. Although there were prominent decreases in LDL and VLDL
levels, as well as increases in HDL levels of the fractions-treated groups,
these changes were not significant (p > 0.05) when compared to control
group. The standard drug, glibenclamide, caused significant (p < 0.05)
reductions in LDL and VLDL levels (Table 5).
Effects on the FBG levels of alloxan-induced diabetic rats during acute
treatment
The leaf fractions, 2 h post treatment, exerted considerable reductions in FBG of the diabetic rats which were significant at the 7 h (p
< 0.05–0.001) with the dichloromethane and EA fractions-treated
groups having the most significant (p < 0.01) reductions of FBG. The
effect of the dichloromethane fraction was stronger than that of standard
drug, glibenclamide (7 h) (Table 2).
Histological studies of the pancreas
Histopathological study of pancreas of untreated diabetic rats treated
with normal saline only (10 mL/kg) at X400 revealed distorted pancreas
with areas of islets cells degeneration with very few cells, degranulated
islet cells and degranulated β-cells and α-cells as well as areas of reduced
islet cells. Pancreas of diabetic rats treated with glibenclamide and leaf
fractions revealed some normal areas though with few areas of reduced
islet cells of Langerhans than normal, degranulated or degenerated cell,
thereby showing a significant protective effect (Fig. 3).
Antidiabetic activities of the leaf fractions during prolonged treatment
The leaf fractions caused significant (p < 0.05–0.001) and sustained
lowering of FBG levels of the diabetic rats throughout the duration of the
study. The effect of the standard drug, glibenclamide was higher than
that of the solvents fractions. On the last day of the study (day 14), the
FBG levels of all the groups treated with the fractions were reduced
significantly (p < 0.001) with EA fraction exerting the highest effect
followed by n-hexane and dichloromethane fractions which exert comparable effects (Table 3).
Identification of compounds
Five compounds were isolated and identified using FT-IR, 1H and 13C
NMR (Supplementary materials) and GC-MS along with comparison
with literature data as 1-triacontanal, 1-triacontanol, 1-dotriacontanol,
1-triacontyl cerotate, and stigmasterol (Fig. 4). These compounds are
reported for the first time from S. megaphylla.
1-Triacontanal (X16/17), white powder. IR (ATR, νmax, cm−1):
2921, 2854, 1726, 1479, 1461. 1H NMR (400 MHz, CDCl3, δ, ppm), δH
9.70 (1H, t, J = 1.83 Hz, H-1), 2.41 (2H, td, J = 7.34, 1.83 Hz, H-2), 1.63
(2H, m, H-3), 1.25 (16H, brs), 0.88 (3H, t, J = 7.0 Hz, H-30); 13C NMR
(100 MHz, CDCl3, δ, ppm): 14.11 (C-30), 22.10 (C-29), 22.69 (C-28),
29.18 (C-27), 29.36 (C-26), 29.43 (C-25), 29.59 (C-4), 29.70 (C-(5–24)),
31.93 (C-3), 43.92 (C-2), 202.95 (C-1). GC–MS (Rt, 17.918 min). m/z
(relative%): 418.4 [M - H2O]+ (10), 268.1 (5), 147.0 (5), 96 (50), 82
(60), 71.1 (95), 57.1 (100). GC–MS was consistent with data reported by
Tulloch. (1987). The NMR data of 1-triacontanal were first reported.
1-Triacontanol and 1-Dotriacontanol (ratio 1:3 by GC–MS, N15),
Effect of leaf fractions on glycosylated hemoglobin level
There was significant (p < 0.001) reduction of Hb1Ac levels in
fractions-treated groups with the hexane and dichloromethane groups
exerting the highest reductions. The effect of the hexane group was more
than that of the standard drug, glibenclamide. The hexane group was
followed by DCM and EA groups (Fig. 1).
Effect of leaf fractions on insulin level
The solvent fractions treatment significantly (p < 0.05–0.01)
increased the serum insulin levels of the respective treated groups
relative to control. These increases were highest in the glibenclamide
Table 2
Antidiabetic effect of leaf fractions of Setaria megaphylla on BGL of alloxan- induced diabetic rats during acute study.
Treatment
Dose
mg/kg
Blood glucose level mg/dl in hours
0 hr
1 hr
2 hr
3 hr
5 hr
Control normal saline
Glibenclamide
n-hexane fraction
Dichloromethane fraction
Ethyl acetate fraction
Methanol fraction
10 mL/kg
10
200
200
200
200
342.0
344.0
334.6
314.3
301.0
319.6
243.0 ± 2.94
203.3 ± 75.76
198.6 ± 40.20
182.0 ± 58.34
187.6 ± 59.53
233.33 ± 77.28
248.66 ± 57.56
192.6 ± 55.36
234.6 ± 57.81
154.33 ± 42.55
170.33 ± 57.62
214.33 ± 92.96
312.6 ±
171.3 ±
273.0 ±
156.6 ±
188.0 ±
230.6 ±
± 47.60
± 87.55
± 58.85
± 77.62
± 72.38
± 87.18
243.0 ± 49.56
272.6 ± 87.41
242.0 ± 42.93
202.33±68.00
217.3 ± 70.33
276.0 ± 77.39
Data are expressed as MEAN ± SEM, Significant at ap < 0.05, bp < 0.01, cp < 0.001, when compared to control. (n = 6).
4
7 hr
65.59
64.86
71.93
64.87a
76.70
84.76
326.22 ± 45.28
184.3 ± 61.18 c
275.5 ± 44.23c
113.33 ± 13.77c
186.2 ± 45.23c
226.7 ± 65.33c
J.E. Okokon et al.
Phytomedicine Plus 2 (2022) 100182
Table 3
Antidiabetic effect of solvent leaf fractions of Setaria megaphylla on blood glucose level of alloxan- induced diabetic rats during prolonged study.
Treatment
Dose
mg/kg
Blood glucose level mg/dl in hours
0 hr
24 hr
3rd day
5th day
7th day
10th day
14th day
Control normal saline
Glibenclamide
n-hexane fraction
Dichloromethane fraction
Ethyl acetate fraction
Methanol fraction
10 mg/ml
10
200
200
200
200
342.0 ±
344.0 ±
334.6 ±
314.3 ±
301.0 ±
319.6 ±
312.6
159.3
148.5
123.0
134.0
143.0
206.33±27.84
85.6 ± 3.52b
133.3 ± 4.91c
118.0 ± 4.04c
123.6 ± 2.60c
190.3 ± 4.57
196.66±34.78
76.0 ± 6.92c
73.0 ± 2.30c
94.66 ± 6.00c
90.33 ± 2.02c
83.66±7.42
176.3 ± 10.13
74.0 ± 6.65c
79.66 ± 7.21c
80.00 ± 4.93c
92.33 ± 21.75c
77.0 ± 10.97c
145.3 ± 22.78
61.3 ± 6.36c
78.0 ± 8.08c
77.66 ± 4.33c
90.66 ± 2.99c
70.66 ± 8.19c
47.60
87.55
58.85
77.62
72.38
87.18
320.0 ±
325.6 ±
346.0 ±
184.3 ±
248.3 ±
354.3 ±
52.15
52.44
86.52
40.53
90.03
74.46
± 65.59
± 5.34 c
± 9.20c
± 5.94c
± 4.00c
± 9.57
Data is expressed as MEAN ± SEM, Significant at ap < 0.05, bp < 0.01, cp < 0.001, when compared to control. (n = 6).
Fig. 1. Effect of solvent leaf fractions of Setaria megaphylla on glycosylated hemoglobin concentration of alloxan-induced diabetic rats. Data is expressed as MEAN ±
SEM. Significant at *p < 0.05, **p < 0.01, ***p < 0.001, when compared to control. (n = 6).
Stigmasterol ((24S)−5,22-Stigmastadien-3β-ol, PJ3); white powder. FT-IR (ATR, νmax, cm−1): 2918, 2851, 1732, 1479, 1290. C29H48O,
MW= 412.37. 1H NMR (400 MHz, CDCl3) δ: 0.69 (3H, d, J = 7.3 Hz,
CH3–21), 0.81 (3H, t, J = 7.0, CH3–29), 0.90 (3H, d, J = 6.4 Hz,
CH3–26), 1.01 (3H, d, J = 7.5 Hz, CH3–27), 1.25 (3H, s, CH3–18), 3.53
(1H, m, H-3), 5.02 (dd, 1H, J = 8.6, 15.0 Hz, H-22), 5.16 (1H, dd, J =
6.6, 15.2 Hz, H-23) and 5.34 (1H, d, J = 4.9 Hz, H-6). 13C NMR (100
MHz, CDCl3) δ: 140.77 (C-5), 138.32 (C-22), 129.30 (C-23), 121.72 (C6), 71.84 (C-3), 56.89, 55.99, 50.19, 42.33, 40.49, 39.70, 37.28, 36.53,
31.92, 31.69,29.71, 28.92, 25.41, 24.38, 21.22 (C-21), 21.09 (C27),
19.41 (C-19), 18.99 (C-26), 12.25 (C-29), 12.06 (C-18). GC–MS (Rt,
17.813 min), m/z (%): 412.2 [M]+(25), 351.3 (5), 300.1 ((8), 255.2
(20), 213.1 (8), 145.0 (25), 105.0 (40), 55. 0 (100). NMR data are
consistent with those reported (Chen et al., 2021).
white powder, FT-IR (ATR, νmax, cm−1): 3275, 2918, 2854, 1467, 1064.
H NMR (400 MHz, CDCl3+CH3OD (9:1)), δH 0.80 (t, J = 7.0 Hz, 3H),
1.22 (brs, 54–58 H), 1.50 (2H, m), 3.60 (t, J = 5.0 Hz, 2H); 13C NMR
(100 MHz, CDCl3+CH3OD (9:1)), δ: 62.62 (C-1), 32.56 (C-2), 31.86 (C3), 29.62 (C-4), 29.56 (20C and 22C, C-5–25 and 5–27), 29.40, 29.28,
25.70, 22.61, 13.98. GC–MS, TMSi-Triacontanol: m/z (Relative%):
595.5 [M-15]+ (100), 75 (35), 57.0 (40), 43.0 (35). TMSiDotriacontanol: m/z (relative %): 523.6 [M-15]+ (100), 75 (35), 57.0
(40), 43.0 (35). These NMR data are in agreement with those reported
for 1-triacontanol (Mahmuod et al., 2021), and 1-dotriacontanol
(Parmer et al., 1998).
1-Triacontyl cerotate (X1). White solid, IR (ATR, νmax, cm−1): 2925,
2853, 1743, 1471, 1175; 1H NMR (400 MHz, CDCl3) δ: 4.05 (t, J = 6.8
Hz, 2H, -CH2O), 2.30 (t, J = 7.0 Hz, 2H, -CH2CO), 1.61 (quin, J = 7.0 Hz,
4H, -CH2CH2O and –CH2CH2CO), 1.33–1.24 (m, 98 H, 49 x CH2), 0.88 (t,
J = 7.0 Hz, 6H, 2 x CH3); 13C NMR (100 MHz, CDCl3) δ 14.12, 22.70,
25.06, 25.96, 28.68, 29.18, 29.27, 29.37, 29.49, 29.54, 29.62, 29.67,
29.71, 31.94, 34.44 (CH2CO), 64.41 (O–CH2), 174.62 (COO). FT-IR and
NMR data are consistent with reported data (Snehunsu et al., al.,2015).
1
Discussion
Diabetes mellitus, a chronic metabolic disorder, is reportedly associated with increased generation of free radicals especially reactive
5
J.E. Okokon et al.
Phytomedicine Plus 2 (2022) 100182
Fig. 2. Effect of solvent leaf fractions of Setaria megaphylla on insulin levels of alloxan-induced diabetic rats. Data is expressed as MEAN ± SEM. Significant at *p <
0.05, **p < 0.01, ***p < 0.001, when compared to control. (n = 6).
Table 4
Effect of solvent leaf fractions of Setaria megaphylla on Oral glucose tolerance of diabetic rats.
Treatment
Control normal saline
Glibenclamide
n-hexane fraction
Dichloromethane fraction
Ethyl acetate fraction
methanol fraction
Dose
mg/kg
Blood glucose level (mg/dL) in min
0 min
30 min
60 min
120 min
180 min
–
10
200
200
200
200
154.18 ± 44.68
170.28 ± 15.48
176.0 ± 51.22
151.7 ± 2.16
174.74 ± 48.78
183.6 ± 44.10
254.54 ± 33.68(65.09)
97.2 ± 11.80(42.91)
91.8 ± 13.60(47.84)
151.2 ± 8.46(0.32)
137.88 ± 15.22(21.09)
117.54 ± 11.70(35.98)
215.94 ± 39.36(40.05)
67.14 ± 9.00(60.57)
97.2 ± 12.80(44.77)
99.0 ± 9.36(34.73)
122.9 ± 9.90(29.66)
86.94 ± 19.0 (52.64)
192.8 ± 12.96(25.04)
69.48 ± 11.52(59.19)
87.48 ± 14.16(50.29)
85.18 ± 5.04(43.84)
115.2 ± 10.08(34.07)
90.0 ± 8.10(50.98)
293.9 ± 33.24(90.62)
135.0 ± 21.42(20.71)
180.8 ± 55.76(2.72)
283.14 ± 24.48(86.61)
139.68 ± 24.48(20.06)
185.4 ± 44.46(0.98)
Data is expressed as MEAN ± SEM, Significant at ap < 0.05, bp < 0.01, cp < 0.001, when compared to control. (n = 6). Values in parenthesis represent% inhibition of
elevation of blood glucose calculated relative to 0 min.
Table 5
Effect of solvent leaf fractions of Setaria megaphylla on lipid profile of alloxan-induced diabetic rats.
Treatment
Dose mg/kg
Total cholesterol (mMol/L)
Triglyceride (mMol/L)
HDL-C (mMol/L)
LDL-C (mMol/L)
VLDL (mMol/L)
Control
Glibenclamide
n-hexane fraction
Dichloromethane fraction
Ethyl acetate fraction
Methanol fraction
10 mL/kg
10
200
200
200
200
2.70 ± 0.05
2.20 ± 0.11
2.50 ± 0.12
2.70 ± 0.05
2.90 ± 0.05
2.66 ± 0.08
1.47 ± 0.08
1.02 ± 0.11a
1.41 ± 0.03
1.45 ± 0.05
1.58 ± 0.10c
1.50 ± 0.09
1.81 ± 0.08
1.39 ± 0.12
1.70 ± 0.25
1.87 ± 0.06
2.17 ± 0.01
1.95 ± 0.24
1.55 ±
1.27 ±
1.46 ±
1.49 ±
1.47 ±
1.38 ±
0.67 ± 0.04
0.46 ± 0.04a
0.63 ± 0.01
0.65 ± 0.02
0.71 ± 0.04
0.67 ± 0.04
0.09
0.03
0.08
0.11
0.03
0.15
Data is expressed as MEAN ± SEM, Significant at ap < 0.05, bp < 0.01, cp < 0.001, when compared to control. (n = 6).
oxygen species (ROS) (Okutana et al., 2005; Papachristoforou et al.,
2020). Alloxan, which was used to induce diabetes in this study is reported to be biotransformed to dialuric acid with accompanying generation of free radicals (Mathews and Leiter, 1999) and subsequently,
partial destruction of pancreatic β-cells of islet of Langerhans (Abdel-Barry et al., 1997). This reduces insulin level resulting in type 2 diabetes
mellitus (Ighodaro et al., 2017), with some remnant pancreatic β-cells
having insulin producing potentials as observed in a study with hypoglycemic agents like sulphonylureas in alloxan-induced diabetic rats
(Subramoniam et al., 1996). The insulin deficiency resultantly stimulates lipolysis in adipose tissues and gives rise to hyperlipidemia
(Ahmad et al., 2014).
In this study, S. megaphylla leaf fractions demonstrated sustained
significant antidiabetic activities during acute and prolonged studies
with dichloromethane, ethyl acetate and n-hexane fractions exerting
prominent activities. The FBG levels of the treated diabetic rats were
significantly reduced when compared to those of untreated diabetic rats
(control). The antidiabetic results observed in this study corroborate
those of previous reports (Okokon and Antia, 2007; Okokon et al.,
2007a). Thus, confirming and validating the antidiabetic potentials of
this plant in ethnomedicine.
Diabetes mellitus causes body glucose regulatory processes to be
compromised leading to chronic hyperglycemia (Champe et al., 2005).
The observed reduced FBG of diabetic rats following treatment with the
leaf fractions suggests blood glucose lowering potentials probably
through insulin secretion stimulation as was observed in this study.
The solvents fractions were observed to cause elevation of serum
insulin levels of the diabetic rats with n-hexane fraction producing the
highest effect followed by DCM fraction. These fractions were observed
to offer considerable protection to the pancreas of the diabetic rats and
may account for the high insulin levels of the groups. This result suggests
insulin secretion stimulatory potential as well as recovery activities of
injured β-cells in alloxan-induced diabetic rats. These effects may have
resulted from the antioxidative stress activities of the fractions as reported earlier by Okokon et al., al.(2013), and 1-triacontyl cerotate
(Snehunsu et al., 2015), as well as pancreatic cell stimulatory effect of
stigmasterol which is reported to increase serum insulin levels in diabetic rats (Nualkaew et al., 2015), probably through regeneration of
6
J.E. Okokon et al.
Phytomedicine Plus 2 (2022) 100182
Fig. 3. Histological sections of pancreas of alloxan-induced diabetic rats treated with normal saline (control) 10 mL/kg(1), glibenclamide 10 mg/kg bw (2), n-hexane
fraction 200 mg/kg bw (3), dichloromethane fraction 200 mg/kg bw (4), ethyl acetate fraction 200 mg/kg bw(5), methanol fraction 200 mg/kg bw(6) at magnification B(x400), stained with H&E method. Keys: Pancreastic acini (PA), Pancreatic Islets (PI), Pancreastic degeneration (PD).
pancreatic β-cells. The presence of these compounds and earlier reported
compounds (Okokon et al., 2007b, 2013, 2017; Udobang et al., 2017) in
the fractions must have offered protection to the pancreas and β-cells
against the effect of alloxan as observed in the histopathology which
could have been responsible for the high insulin level. Thus, this explains the observed pancreas protection potential.
The solvent fractions were found to considerably reduced FBG levels
of treated diabetic rats during oral glucose tolerance test (OGTT). Oral
glucose tolerance test measures the body’s ability to use glucose, the
main source of energy (Gold, 1970). Lowering of BGL effect was
observed post administration of the solvent fractions with methanol and
hexane fractions exerting the highest inhibition of BGL increases. This
may be due to the activities of phytochemicals present in the solvent
fraction as earlier reported (Okokon et al., 2006, 2013). Blood glucose
level after glucose loading is dependent on insulin secretion, glucose
utilization, intestinal absorption and intestinal motility (Peungvicha
et al., 1996), alternative mechanism by the respective fractions could
have involved insulin secretion stimulation, glucose utilization and inhibition of intestinal absorption and intestinal motility. Naveen and
Baskaran (2018) had reported that the possible modes of natural products action in glycemic control include stimulation of glucose uptake by
tissues, inhibition of intestinal glucose absorption, increased glycogen
synthesis, inhibition of dipeptidyl peptidase-IV (DPP-IV), among others.
In this study, the fractions were observed to improved glucose
tolerance which could be attributable to potentiation of the insulin effect
on the plasma glucose through increased pancreatic insulin secretion
from existing β-cells or its release from bound insulin as was observed in
this study. This could have also resulted from the inhibitory potentials of
the leaf fractions on α-amylase and α-glucosidase activities as reported
earlier by Okokon et al. (2021), thereby inhibiting glucose absorption
from the intestines, in addition to insulin secretion stimulation in
response to glucose load and increased peripheral utilization of glucose
which are the probable mechanisms of antidiabetic action (Andrikopoulos et al., 2008; Regginato et al., 2021).
In uncontrolled diabetes, high level of glycosylation of some proteins
including hemoglobin occurs, contributing to long-term complications
of diabetes (Latha and Pari, 2004). Hb1Ac level usually indicates glycemic control (Daisy and Rajathi, 2009) and significant lowering of
Hb1Ac levels of diabetic rats by the leaf fractions indicates controlled
blood glucose level especially in hexane and dichloromethane
fractions-treated groups. However, high Hb1Ac levels with corresponding increased plasma glucose levels were observed in untreated
diabetic rats. These results corroborate the findings of previous work
(Adeneye and Adeyemi, 2009) and confirm antidiabetic activity of leaf
7
J.E. Okokon et al.
Phytomedicine Plus 2 (2022) 100182
Fig. 4. Chemical structures of isolated and identified compounds from S. megaphylla.
fractions of S. megaphylla via insulin secretion stimulation, resulting in
lowering of BGL and HbA1c levels.
Phytochemical screening of the leaf extract revealed the presence of
saponins, tannins, flavonoids, alkaloids and terpenes (Okokon et al.,
2007). Also, previous GC-MS analysis of the n-hexane fraction of the leaf
revealed the presence of (Z,Z,Z)-8,11,14-eicosatrienoic acid, phthalic
acid, diisooctyl ester, vitamin E, ᵞ-elemene, urs-12-ene, bicyclogermacrene, α-muurolene, germacrene-A, and guaiol among others (Okokon
et al., 2013), while GC-MS analysis of ethyl acetate leaf fraction revealed
the presence of (E)-β-ocimene, p-metha-1(7),8-diene, (3a)-D:A-friedooleannan-3-ol,stigmastone-3,6‑dione(5a), bicyclo[2.2.1] heptan-2-ol, 4,
7,7-trimethyl, p-cymene (Okokon et al., 2017). Borneol, astaxanthin,
α-terpineol, terpinen-4-ol, β-cis-bergamotene, citronellol, germacrene D
among others were reported in dichloromethane fraction and 3-methyl-undecane, hexadecanoic acid, 1,2-benzene dicarboxylic acid, isodecyl
octyl ester, carvacrol, linanlool, camphor, borneol, menthofuran, menthone, α-terpineol, and α-eudesmol were found in n-butanol fraction
(Udobang et al., 2017).
In this study, additional compounds including 1-triacontanal, 1-triacontanol, 1-dotriacontanol, 1-triacontyl cerotate, and stigmasterol
were isolated and identified. Some of these phytochemicals in these
fractions may in part be responsible for the observed activities of these
fractions either singly or in synergy. Several plants rich in terpenes, such
as sesquiterpenes and monoterpenes as found in this leaf fractions have
been shown to have an effect on blood glucose levels (Alam et al., 2018;
Belhadj et al., 2018; Ding et al., 2018) by stimulating insulin secretion
and glucose uptake, improving glycogen synthesis and inhibiting
α-glucosidase (Zhao et al., 2012; Naveen and Baskaran, 2018). According to Brahmachari (2011), flavonoids also exhibit glycaemic control and also could regulate the rate-determining enzymes vital for
metabolic pathways of carbohydrate. Similarly, several studies have
shown that ß-sitosterol, stigmasterol, betulin, ergost-8(14)-en-3-ol,
n-hexadecanoic acid, and palmitic acid exert hypoglycemic effects by
reducing the absorptions of cholesterol from the gut ((Rajasekaran et al.,
2006); Gosh et al., 2014) and their presence in these fractions could
likely be responsible for the observed antidiabetic activity
Hyperglycemia and associated diabetic dyslipidemia lead to several
comorbidities including macro-and microvascular damage (Naveen and
Baskaran, 2018). Elevated blood glucose levels equally gives rise to low
levels of HDL cholesterol and escalation of LDL cholesterol, thus
increasing risk of coronary heart diseases (Sudasinghe and Peiris, 2018).
Additionally, stimulation of catabolic activity and increased mobilization of free fatty acids from peripheral deposits by diabetic condition as
well as lipolytic action of hormones and inhibition of hormone sensitive
lipase production by insulin result in elevated lipid levels, thereby,
increasing the risk of myocardial dysfunction (Rojop et al., 2012).
Therefore, both diabetes and lipid levels must be managed properly to
achieve a satisfactory treatment outcome. The leaf fractions were found
to have insignificant lowering effect on total cholesterol, TG, VLDL and
LDL levels of the diabetic rats and considerably increased the level of
HDL –cholesterol in the diabetic rats. The administration of the fractions
may have partly increased glucose utiization, thereby suppressing fats
mobilization and lipolysis involving plasma lipoprotein lipase, though
not significantly (BenKhedher et al., 2018).
Plants sterol such as stigmasterol present in the dichloromethane
fraction exerts antihyperlipidemic activity through different mechanisms to inhibit the absorption of cholesterol from the gut (Batta et al.,
2006). The antihyperlipidemic effects observed in this study may have
resulted from the activities of this and other phytochemical compounds.
Body weight loss which is due to increased muscle wasting and loss
of tissue proteins is common in diabetic rats (Shirwaikar et al., 2005).
Treatment with the leaf fractions especially ethyl acetate and hexane
fractions, remedied this situation perhaps due to the chemical constituents of these fractions which have the ability to reduce hyperglycaemia
by increased glucose metabolism, inhibition of α-amylase and α-glucosidase enzymes, and protein synthesis stimulation thereby suppressing
muscle wasting through reversal of gluconeogenesis (Mestry et al.,
2017).
Alloxan monohydrate has been reported to cause various injuries to
the pancreas which results in partial destruction of pancreatic β-cells of
islet of Langerhans (Abdel-Barry et al., 1997). The pancreas of untreated
diabetic rats were observed to have areas of islets cell degeneration,
degranulated islet, degranulated β- and α- cells as well as reduced islet
cells among others. These pathologic features were not prominent in the
8
J.E. Okokon et al.
Phytomedicine Plus 2 (2022) 100182
leaf fractions treated groups, suggesting regenerative effect of the
extract. The phytoconstituents in these leaf fractions such as stigmasterol, hexadecanoic acid and 1-triacontanol cerotate among others,
through their antioxidative effect, could have caused the regeneration of
the pancreas and increased level of insulin in treated diabetic rats in this
study resulting in hypoglycaemic activity. The protection maybe due to
the free radical scavenging potentials of the leaf fractions as reported by
Okokon et al.,(2013) and recently by Umana (2021) which revealed
strong antioxidant potentials of the hexane and ethyl acetate fractions of
the leaf extract in the various in vitro models. This activity inherent in
the leaf extract/fractions could have counteracted the vast free radicals
generated by alloxan and the diabetic condition thereby leading to the
observed antidiabetic and pancreas protective effects in this study.
However, this study could not determined the quantities of these
identified and isolated compounds in the fractions, which is necessary
for the standardization of the extract/fractions in order to be used
effectively and safely nor established the antioxidant and antidiabetic
activities of the isolated compounds. These were the limitations of this
study which further study has been recommended to be carried out on
the leaf extract.
Pharmacognosy and Natural medicine, University of Uyo, Uyo, Nigeria.
The authors are grateful to the management of University of Uyo for
providing the enabling environment to carry out this work and Mr
Nsikan Malachy of Pharmacology and Toxicology Department for
providing technical assistance. We thank Dr. Sian Woodfine and Falko
Drijfhout at Keele University for recording NMR and obitrap MS spectra,
respectively.
Supplementary materials
Supplementary material associated with this article can be found, in
the online version, at doi:10.1016/j.phyplu.2021.100182.
References
Abdel-Barry, J.A., Abdel-Hassan, I.A., Al-Hakiem, M.H., 1997. Hypoglycemic and
antihyperglycemic effects of trigonella foenum-graecum leaf in normal and alloxaninduced diabetic rats. J. Ethnopharmacol 58, 149–155.
Adeneye, A.A., Adeyemi, O.O., 2009. Further evaluation of antihyperglycaemic activity
of Hunteria umbellata (K. Schum) Hallier f. seed extract in experimental diabetes.
J. Ethnopharmacol 126 (2), 238–243.
Ahmad, W., Khan, I., Khan, M.A., Ahmad, M., Subhan, F., Karim, N., 2014. Evaluation of
antidiabetic and antihyperlipidemic activity of Artemisia indica linn (aeriel parts) in
Streptozotocin induced diabetic rats. J. Ethnopharmacol 151, 618–623.
Alam, M.B., An, H., Ra, J.S., Lim, J.Y., Lee, S.H., Yoo, C.Y., Lee, S.H., 2018. Gossypol
from cottonseeds ameliorates glucose uptake by mimicking insulin signaling and
improves glucose homeostasis in mice with streptozotocin-induced diabetes. Oxid.
Med. Cell. Longev 5796102, 1–11. Article ID.
Aldulaimi, O., Uche, F.I., Hameed, H., Mbye, H., Ullah, I., Drijfhout, F., Claridge, T.D.,
Horrocks, P., Li, W.W., 2017. A characterization of the antimalarial activity of the
bark of Cylicodiscus gabunensis Harms. J. Ethnopharmacol. 198, 221–225.
Andrikopoulos, S., Blair, A.R., Deluca, N., Fam, B.C., Proietto, J., 2008. Evaluating the
glucose tolerance test in mice. Am. J. Physiol.-Endocrinol. Metab 295,
E1323–E1332.
Badri, K.R., Rajasekhar, M.D., Aramgam, S., Apparao, C., 2006. Treatment of diabetes
mellitus: plant drugs vs oral hypoglycemic agents and insulin. Recent Progress
Medicinal Plants 14:279–296.
Bailey, C.J., 2004. Metformin: its botanical background. Pract. Diabetes Int 21 (3),
115–117.
Basu, S., Millett, C., Vijan, S., Hayward, R.A., Kinra, S., Ahuja, R., Yudkin, J.S., 2015. The
Health System and Population Health Implications of Large-Scale Diabetes Screening
in India: A Microsimulation Model of Alternative Approaches. PLoS Med 12 (5),
e1001827. https://doi.org/10.1371/journal.pmed.1001827.
Batta, A.K., Xuab, G., Honda, A., Miyazaki, T., Salen, G., 2006. Stigmasterol reduces
plasma cholesterol levels and inhibits hepatic synthesis and intestinal absorption in
the rat. J. Pharm. Sci. 55 (3), 292–299.
BenKhedher, M.R.B., Hammami, M., Arch, J.R.S., Hislop, D.C., Eze, D., Wargent, E.T.,
Kepczyriska, M.A., Zaib, M.S., 2018. Preventive effects of Saliva officinalis leaf
extract on insulin resistance and inflammation in a model of high diet-induced
obesity in mice tat respond to rosiglitazone. Peer J. 6, e4166.
Belhadj, S., Hentati, O., Hammami, M., Ben Hadj, A., Boudawara, T., Dammak, M.,
Zouari, S., El Feki, A., 2018. Metabolic impairments and tissue disorders in alloxaninduced diabetic rats are alleviated by Salvia officinalis L. essential oil. Biomed.
Pharmacother. 108, 985–995.
Brahmachari, G., 2011. Bio-flavonoids with promising anti-diabetic potentials: a critical
survey. In: Tiwari, VK (Ed.), Opportunity, Challenge and Scope of Natural Products
in Medicinal Chemistry. Research Signpost, Kerala, pp. 187–212.
Champe, P.C., Harvey, R.A., Ferrier, D.R., 2005. Biochemistry. Lippincott’s Illustrated
Reviews. 3rd ed. Lippincot Williams and Wilkins, New York, Pp. 305–318.
Chen, Y., Wu, Y., Li, S., Du, S., Hao, X., Zhang, J., Gu, P., Sun, J., Jiang, L., Gai, Q.,
Liu, X., Nie, K., Zhong, L., Wang, G., Cao, J., 2021. Large-scale isolation and
antitumor mechanism evaluation of compounds from the traditional Chinese
medicine Cordyceps Militaris. Eur. J. Med. Chem 212, 113142.
Clarkson, C., Maharay, V.J., Crouch, N.R., Grace, O.M., Pillay, P., Matsabisa, M.G.,
Bhagwandin, N., Smith, P.J., Folb, P.I., 2004. In vitro antiplasmodial activity of
medicinal plants native to or naturalized in South Africa. J. Ethnopharmacol. 92,
177–191.
Daisy, P., Rajathi, M., 2009. Hypoglycemic effects of Clitoria ternatea linn. (Fabaceae) in
Alloxan-induced diabetes in rats. Trop. J. Pharm. Res. 8, 393–398.
Ding, H., Wu, X., Pan, J., Hu, X., Gong, D., Zhang, G., 2018. New insights into the
inhibition mechanism of betulinic acid on glucosidase. J. Agric. Food Chem. 66 (27),
7065–7075.
Ezuruike, U.F., Prieto, J.M., 2014. The use of plants in the traditional management of
diabetes in Nigeria: pharmacological and toxicological considerations.
J. Ethnopharmacol 155 (2), 857–924.
Festing, M.F., 2006. Design and statistical methods in studies using animal models of
development. Inst. Laboratory Animal Res. J. 47, 5‑14.
Finlay, J.W.A., Dillard, R.F., 2007. Appropriate calibration curve fitting in ligand binding
assays. Am. Assoc. Pharm. Scientists Jo. 9 (2), E260–E267.
Friedewald, W.T., Levy, R.I., Fredrickson, D.S., 1972. Estimation of the concentration of
low density lipoprotein cholesterol in plasma, without use of the preparative
ultracentrifuge. Clin. Chem. 18 (6), 499–502.
Conclusion
The results of this study show that the leaf fractions of S. megaphylla
possess antidiabetic, hypolipidemic and pancreas protective potentials,
which may be partially attributed to the identified compounds from this
plant.
Ethics approval and consent to participate
Permission and approval for animal studies were obtained from
College of Health Sciences Animal Ethics committee, University of Uyo
(UU/CHS/AE/21/024).
Consent for publication
All the authors read and approved the final content of this manuscript for publication.
Availability of data and material
All data generated in this project were included in this manuscript,
supplementary materialsand stored in our computer hard drive and
external storage drive which will be available upon request.
Authors’ statements
Jude E. Okokon designed and supervised the work, Lekara John and
Klinton Iwara carried the animal studies, Koofreh Davies did the statistical analysis, Paul S. Thomas carried out the isolation and purification of the compounds, Wen-Wu Li did the GC–MS and NMR analysis
and interpretation of the spectra and also edited the work.
All data were generated in-house, and no paper mill was used. All
authors agree to be accountable for all aspects of work ensuring integrity
and accuracy.
Declaration of Competing Interest
The authors declare that there are no competing interests regarding
the publication of this paper.
Acknowledgements
This research work did not receive any grant from government, profit
and nonprofit organizations. Research was conducted in the Department
of Pharmacology and Toxicology as well as Department of
9
J.E. Okokon et al.
Phytomedicine Plus 2 (2022) 100182
Ghosh, T., Ghosh, S., Maity, T., 2014. Antihyperglycemic activity of stigmasterol isolated
from Bacopa monnieri Linn. aerial parts against alloxan induced diabetic rats. Int. J.
Nat. Prod. Res. 4 (2), 40–46.
Gold, A.H., 1970. The effect of diabetes and insulin on liver glycogen synthetase
activation. J. Biol. Chem. 245–903.
Latha, M., Pari, L., 2004. Effect of an aqueous extract of Scoparia dulcis on blood glucose,
plasma insulin and some polyol pathway enzymes in experimental rat diabetes. Braz.
J. Med. Biol. Res. 37, 577–586.
Lenzen, S., 2008. The mechanisms of alloxan- and streptozotocin-induced diabetes.
Diabetologia 51 (2), 216–226.
Khan, V., Najmi, A.K., Akhtar, M., Aqil, M., Mujeeb, M., Pillai, K.K., 2012.
A pharmacological appraisal of medicinal plants with antidiabetic potential.
J. Pharm. Bioall. Sci. 4, 27.
Ighodaro, O.M., Adeosun, A.M., AdeboyeAkinloye, O., 2017. Alloxan-induced diabetes, a
common model for evaluating the glycemic-control potential of therapeutic
compounds and plants extracts in experimental studies. Medicina (B Aires) 53 (6),
365–374.
Mahmoud, T.N., El-Maadawy, W.H., Kandil, Z.A., Khalil, H., El-fiky, N.M., El Alfy, T.,
2021. Canna x generalis L.H. Bailey rhizome extract ameliorates dextran sulfate
sodium-induced colitis via modulating intestinal mucosal dysfunction, oxidative
stress, inflammation, and TLR4/NF-B and NLRP3 inflammasome pathways.
J. Ethnopharmacol. 269, 113670.
Marles, R.J., Farnsworth, N.R., 1995. Antidiabetic plants and their active constituents.
Phytomedicine 2 (2), 137–189.
Mathews, C.E., Leiter, E.H., 1999. Constitutive differences in antioxidant defense status
distinguish alloxan-resistant and alloxan-susceptible mice. Free Radic. Biol. Med. 27,
449–455.
Mestry, S.N., Dhodi, J.B., Kumbhar, S.B., Juvekar, A.R, 2017. Attenuation of diabetic
nephropathy in streptozotocin-induced diabetic rats by Punica granatum Linn.
leaves extract. J. Tradit. Complement. Med. 7, 273–280.
Nathan, D.M., Singer, D.E., Hurxthal, E., Goodson, J.D., 1984. The clinical information
value of the glycosylated hemoglobin assay. N. Engl. J. Med. 310, 341–346.
Naveen, J., Baskaran, V., 2018. Antidiabetic plant-derived nutraceuticals: a critical
review. Eur. J. Nutr. 57 (4), 1275–1299.
Nualkaew, S., Padee, P., Talubmook, C., 2015. Hypoglycemic activity in diabetic rats of
stigmasterol and sitosterol-3-0-β-D-glucopyranoside isolated from Pseuderanthemum
palatifurum (Ness) Radlk. leaf extract. J. Med. Plant Res. 9 (20), 629–635.
Okokon, J.E., Antia, B.S., 2007. Hypoglycaemic and antidiabetic effect of Setaria
megaphylla on normal and alloxan induced diabetic Rats. J. Nat. Remedy 1,
134–138.
Okokon, J.E., Antia, B.S., Ita, B.N., 2006. Antiiflammatory and antinociceptive effects of
ethanolic extract of Setaria megaphylla leaves in rodents. Afr. J. Biomed. Res. 9,
229–233.
Okokon, J.E., Bassey, A.L., Nwidu, L.L., 2007a. Antidiabetic and hypolipidaemic activity
of ethanolic root extract of Setaria megaphylla. Int. J. Pharmacol 3 (1), 91–95.
Okokon, J.E., Dar, A., Choudhary, M.I., 2013. Immunomodulatory, cytotoxic and
antileishmanial activities of Setaria megaphylla. Int. J. Phytomed. 4, 155–160.
Okokon, J.E., Otuikor, J.E., Davies, K., 2016. Psychopharmacological study on ethanol
leaf extract of Setaria megaphylla. Afr. J. Pharmacol. Therapeutics 6 (4), 166–172.
Okokon, J.E., Ubulom, P.M., Udokpoh, A.E., 2007b. Antiplasmodial activity of Setaria
megaphylla. Phytother. Res. 21, 366–368.
Okokon, J.E., Okokon, P.J., Sahal, D., 2017. In vitro antiplasmodial activity of some
medicinal plants from Nigeria. Int. J. Herb. Med. 5 (5), 102–109.
Okokon, J.E., Davies, K., Lekara, J., Iwara, K., Kumar, H., 2021. Effect of solvents leaf
fractions of Setaria megaphylla on alpha amylase and alpha glucosidase activities in
rats. Adv. Pharm. J 6 (4), 111–115.
Okokon, J.E., Nyong, M.E., 2018. Antidiabetic and hypolipidemic activities of husk
extract and fractions of Zea mays. J. Herbs, Spices Med. Plants. 24 (2), 134–150.
Okutana, H., Ozcelik, N., Yilmaz, H.R., Uz, E., 2005. Effects of caffeic acid phenethyl
ester on lipid peroxidation and antioxidant enzymes in diabetic rat heart. Clin.
Biochem. 38, 191–196.
Papachristoforou, E., Lambadiari, V., Maratou, E., Makrilakis, K., 2020. Association of
glycemic indices (hyperglycemia, glucose variability and hypoglycemia) with
oxidative stress and diabetic complications. J Diabetes Res 12, 7489795.
Park, J., Jang, H., 2017. Anti-diabetic effects of natural products an overview of
therapeutic strategies. Mole. Cell. Toxicol. 13, 1–20.
Parmar, V.S., Jain, S.C., Gupta, S., Talwar, S., Rajwanshi, V.K., Kumar, R., Azim, A.,
Malhotra, S., Kumar, N., Jain, R., Sharma, N.K., Tyagi, O.D., Lawrie, S.,
Errington, W., Howarth, O.W., Olsen, O.C., Singh, S.K., Wengel, J., 1998.
Polyphenols and alkaloids from Piper species. Phytochemistry 49 (4), 1069–1078.
Peiris, L.D.C., Dhanushka, M.A.T., Jayatilleka, T.A., 2015. Evaluation of aqueous leaf
extract of Cardiospermum halicacabum (L.) on fertility of male rats. Hindawi.
BioMed Central Res. Int. 1–6.
Rabintossaporn, P., Saenthaweesuk, S., Thuppia, A., Ingkaninan, K., Sireeratawong, S.,
2009. Antihyperglycemic and histological effects on the pancreas of the aqueous
leaves extract of Annona squamosa L. in normal and diabetic rats. Songklanakarin J.
Sci. Technol. 31 (1), 73–78.
Rajasekaran, S., Ravi, K., Sivagnanam, K., Subramanian, S., 2006. Beneficial effects of
Aloe veraleaf gel extract on lipid profile status in rats with streptzotocin diabetes.
Clin. Exp. Pharmacol. Physiol. 33, 232–237.
Regginato, A., Cunico, L., Bertoncello, K.T., Schindler, M.S., Chitolina, R., Marins, K.,
Zanatta, A.P., Calisto, J.F., Oliveira, J.V., Magro, J.D., Zanatta, L., 2021. Antidiabetic
and hypolipidemic potential of Campomanesia xanthocarpa seed extract obtained by
supercritical CO2. Braz. J. Biol. 81 (3), 621–631.
Rojop, I.E., Díaz-Zagoya, J.C., Ble-Castillo, J.L., Miranda-Osorio, P.H., CastellRodríguez, A.E., Tovilla-Zárate, C.A., Bermúdez-Ocaña, D.Y., 2012. Hypoglycaemic
effect of Carica papaya leaves in streptozotocin-induced diabetic rats. BMC
Complement. Altern. Med. 12, 236.
Snehunsu, A., Ghosal, C., Kandwal, M., Yadav, P.K., Nayak, B.S., Rao, K.R., Kamath, S.U.,
Sahoo, P., Srinivasan, K.K., Naduvil Narayanan, S., Kumar, S., Joseph, A., 2015. 1Triacontanol cerotate; isolated from Marsilea quadrifolia Linn. ameliorates reactive
oxidative damage in the frontal cortex and hippocampus of chronic epileptic rats.
J. Ethnopharmacol 172, 80–844.
Saeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., Colagiuri, S.,
Guariguata, L., Motala, A.A., Ogurtsova, K., Shaw, J., Bright, D., Williams, R., 2019.
Global and regional diabetes prevalence estimates for 2019 and projections for 2030
and 2045: results from the international diabetes federation diabetes atlas. Diabetes
Res. Clin. Pract. 157, 107843.
Shirwaikar, A., Rajendran, K., Punitha, I.S.R., 2005. Antidiabetic activity of alcoholic
stem extract of coscinium fenestratum in streptozotocin nicotinamide-induced type 2
diabetic rats. J. Ethnopharmacol 93, 369–374.
Subramoniam, A., Pushpagandan, P., Rajasekharan, S., Evans, D.A., Latha, P.G.,
Valsaraj, R., 1996. Effect of Artemisia pallens Wall on blood glucose levels in normal
and alloxan-induced diabetic rats. J. Ethnopharmacol 50, 13–17.
Sudasinghe, H.P., Peiris, D.C., 2018. Hypoglycemic and hypolipidemic activity of
aqueous leaf extract of Passiflora suberosa L. Peer J. 6, e4389.
Tran, N., Pham, B., Le, L., 2020. Bioactive compounds in anti-diabetic plants:from herbal
medicine to modern drug discovery. Biology (Basel) 9, 252.
Tulloch, A.P., 1987. Epicuticular waxes of Abies balsamea and Picea glauca: occurrence
of long-chain methyl esters. Phytochemistry 26 (4), 1041–1043.
Udobang, J.,.A., Okokon, J.E., 2017. Evaluation of nephroprotective effects of Setaria
megaphyla (Steud) T. Durand sphinz (Poaceae) root extract on paracetamol-induced
injury in rats. Int. J. Herb. Med. 5 (5), 27–31.
Umana, I.K., 2021. Antidotal and antioxidant effects of ethanol leaf extract and fractions
of Setaria megaphylla against chemically induced kidney and liver injuries. Ph.D
Thesis. University of Uyo, Uyo, Nigeria.
Van Oudtshoorn, F.P., 1999. Guide to Grasses of South Africa. Briza Publications, Cape
Town.
World Health Organisation, 1980. WHO expert committee on diabetes mellitus: second
report. WHO Technical Report Ser. 646, 1–80.
World Health Organization. 2017. Global Reports On Diabetes. Available at http://apps.
who.int/iris/bitstream/10665/204871/1/9789241565257_eng.pdf.
Zhao, G., Li, X., Chen, W., Xi, Z., Sun, L., 2012. Three new sesquiterpenes from Tithonia
diversifolia and their anti-hyperglycemic activity. Fitoterapia 83 (8), 1590–1597.
10